Remove Disease Remove Doctors Remove Organic Chemistry Remove Protein Production
article thumbnail

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

Jens Fischer, PhD, Program Manager, Large Molecule Research Therapeutic Modalities, Roche Pharma Research and Early Development (pRED), on: ‘ Bispecific and next-generation antibodies for non-oncology indications such as ophthalmologic and neurologic diseases’.